Compass Patient

Veeva Compass Patient offers anonymous patient longitudinal data (APLD) tailored to the U.S. market, encompassing dispensed prescriptions, procedures, and diagnoses. This APLD is beneficial for diverse commercial operations, notably patient journey analysis, in-depth analytics, and market sizing. The data originates from claims and various other sources, crafted to meet the demands of today's complex therapies.

With licensing on a brand basis, it includes unlimited data access through the Compass portal. A substantial data network supports it, covering over 300 million patients and more than 3 million healthcare providers and clinicians, along with access to over 100 billion prescription and medical records.

Benefits:

• Better visibility and insights: Discover new patients and healthcare professionals with extensive data and enhanced medical claims coverage.
• Immediate data access: Access, query, and retrieve record-level data for any application, at any moment.
• Daily data updates: Enable prompt and timely engagement while tracking market dynamics as they unfold.
• Support for commercial scenarios: Gain a comprehensive understanding of market trends and patient needs at each phase of the brand lifecycle.

Events such as market engagement can be accelerated with the capability to process queries that once took weeks to resolve in mere hours or days. Simeon, a Senior Director at Karuna Therapeutics, highlights how this data aids in addressing questions efficiently, while Bob Acropolis from ANI Pharmaceuticals commends the immediate insights garnered from their usage.